Il y a eu 50 transactions d'initiés récentes enregistrées pour Virpax Pharmaceuticals, Inc. (VRPX), dont 38 achats et 3 ventes. Le total des achats d'initiés s'élève à $1.98M et le total des ventes d'initiés à $333.22K.
Les initiés notables ayant une activité récente comprennent Panis Jaydriane, Randhawa Esha, Chaudhry Usama. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — VRPX
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2024-12-17 |
Panis Jaydriane |
Director |
Inconnu |
- |
- |
- |
- |
| 2024-11-19 |
Randhawa Esha |
Director |
Inconnu |
- |
- |
- |
- |
| 2024-11-18 |
Chaudhry Usama |
Officer |
Inconnu |
- |
- |
- |
- |
| 2024-07-05 |
Herman Gary L |
Director |
Inconnu |
- |
- |
- |
- |
| 2024-07-05 |
Herman Gary L |
Director |
Attribution de RSU |
2,500 |
$0.58 |
$1.45K |
2,500 |
| 2024-07-05 |
Dhaliwal Jatinder |
Director |
Inconnu |
- |
- |
- |
- |
| 2024-07-05 |
Dhaliwal Jatinder |
Director |
Attribution de RSU |
2,500 |
$0.58 |
$1.45K |
2,500 |
| 2024-07-05 |
Field Katharyn |
Director |
Inconnu |
- |
- |
- |
- |
| 2024-07-05 |
Field Katharyn |
Director |
Attribution de RSU |
2,500 |
$0.58 |
$1.45K |
2,500 |
| 2024-07-05 |
Su Judy |
Director |
Inconnu |
- |
- |
- |
- |
| 2024-01-29 |
Bruce Gerald W |
Chief Executive Officer |
Attribution de RSU |
125,000 |
$0.32 |
$39.73K |
125,000 |
| 2024-01-29 |
Shah Vinay |
Chief Financial Officer |
Attribution de RSU |
112,000 |
$0.32 |
$35.59K |
112,000 |
| 2024-01-29 |
Singh Vanila |
Director |
Attribution de RSU |
25,000 |
$0.32 |
$7.95K |
25,000 |
| 2024-01-29 |
Jambulingam Thani |
Director |
Attribution de RSU |
25,000 |
$0.32 |
$7.95K |
25,000 |
| 2024-01-29 |
Floyd Eric |
Director |
Attribution de RSU |
45,000 |
$0.32 |
$14.3K |
45,000 |
| 2024-01-29 |
Sendrow Jerrold |
Director |
Attribution de RSU |
25,000 |
$0.32 |
$7.95K |
25,000 |
| 2024-01-29 |
Dubin Michael F |
Director |
Attribution de RSU |
25,000 |
$0.32 |
$7.95K |
25,000 |
| 2024-01-29 |
Ruskin Barbara |
Director |
Attribution de RSU |
25,000 |
$0.32 |
$7.95K |
25,000 |
| 2024-01-29 |
Mathias Sheila |
Chief Scientific Officer |
Attribution de RSU |
112,000 |
$0.32 |
$35.59K |
112,000 |
| 2024-01-25 |
Mathias Sheila |
Chief Scientific Officer |
Cession |
112,000 |
$0.79 |
$88.48K |
- |
| 2023-06-20 |
Shah Vinay |
Chief Financial Officer |
Attribution de RSU |
100,000 |
$0.99 |
$99K |
100,000 |
| 2023-06-20 |
Shah Vinay |
Officer |
Inconnu |
- |
- |
- |
- |
| 2023-06-20 |
Shah Vinay |
Chief Financial Officer |
Attribution de RSU |
100,000 |
$0.99 |
$99K |
100,000 |
| 2023-04-24 |
Bruce Gerald W |
Director |
Attribution de RSU |
100,000 |
$0.73 |
$73K |
100,000 |
| 2023-03-24 |
Ruskin Barbara |
Director |
Inconnu |
- |
- |
- |
- |
| 2023-03-24 |
Ruskin Barbara |
Director |
Attribution de RSU |
25,000 |
$0.84 |
$20.91K |
25,000 |
| 2023-01-31 |
Mathias Sheila |
Chief Scientific Officer |
Cession |
60,676 |
$2.13 |
$129.24K |
- |
| 2023-01-25 |
Chipman Christopher Michael |
Chief Financial Officer |
Attribution de RSU |
112,000 |
- |
- |
112,000 |
| 2023-01-25 |
Gudin Jeffrey |
Chief Medical Officer |
Attribution de RSU |
50,000 |
- |
- |
50,000 |
| 2023-01-25 |
Mack Anthony P. |
Chief Executive Officer |
Attribution de RSU |
125,000 |
- |
- |
125,000 |
| 2023-01-25 |
Mack Anthony P. |
10 Percent Owner, Officer: Chief Executive Officer |
Attribution de RSU |
125,000 |
$0.87 |
$108.38K |
125,000 |
| 2023-01-01 |
Singh Vanila |
Director |
Attribution de RSU |
15,000 |
- |
- |
15,000 |
| 2023-01-01 |
Jambulingam Thani |
Director |
Attribution de RSU |
40,000 |
- |
- |
40,000 |
| 2023-01-01 |
Floyd Eric |
Director |
Attribution de RSU |
45,000 |
- |
- |
45,000 |
| 2023-01-01 |
Sendrow Jerrold |
Director |
Attribution de RSU |
35,000 |
- |
- |
35,000 |
| 2023-01-01 |
Dubin Michael F |
Director |
Attribution de RSU |
20,000 |
- |
- |
20,000 |
| 2022-05-24 |
Sendrow Jerrold |
Director |
Achat Informatif |
4,500 |
$1.29 |
$5.81K |
9,006 |
| 2022-05-18 |
Floyd Eric |
Director |
Achat Informatif |
4,479 |
$1.36 |
$6.11K |
8,018 |
| 2022-05-18 |
Mack Anthony P. |
Chief Executive Officer |
Achat Informatif |
75,750 |
$1.34 |
$101.51K |
252,562 |
| 2022-04-25 |
Bruce Gerald W |
Director |
Attribution de RSU |
60,000 |
- |
- |
60,000 |
| 2022-04-07 |
Mathias Sheila |
Chief Scientific Officer |
Cession |
25,000 |
$4.62 |
$115.5K |
- |
| 2022-01-31 |
Chipman Christopher Michael |
Chief Financial Officer |
Attribution de RSU |
100,000 |
$2.13 |
$213K |
100,000 |
| 2022-01-31 |
Gudin Jeffrey |
Chief Medical Officer |
Attribution de RSU |
100,000 |
$2.13 |
$213K |
100,000 |
| 2022-01-31 |
Mack Anthony P. |
10 Percent Owner, Officer: Chief Executive Officer |
Attribution de RSU |
150,000 |
$2.34 |
$351K |
150,000 |
| 2022-01-31 |
Chipman Christopher Michael |
Chief Financial Officer |
Attribution de RSU |
60,676 |
$2.13 |
$129.24K |
60,676 |
| 2022-01-31 |
Gudin Jeffrey |
Chief Medical Officer |
Attribution de RSU |
60,676 |
$2.13 |
$129.24K |
60,676 |
| 2022-01-31 |
Mack Anthony P. |
10 Percent Owner, Officer: Chief Executive Officer |
Attribution de RSU |
60,676 |
$2.13 |
$129.24K |
60,676 |
| 2022-01-01 |
Jacob Gary S |
Director |
Attribution de RSU |
12,091 |
$3.43 |
$41.47K |
12,091 |
| 2022-01-01 |
Singh Vanila |
Director |
Attribution de RSU |
12,091 |
$3.43 |
$41.47K |
12,091 |
| 2022-01-01 |
Jambulingam Thani |
Director |
Attribution de RSU |
14,113 |
$3.43 |
$48.41K |
14,113 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi